Charles River Laboratories (CRL)
$214.34+0.77%
Spriggl Score: Moderate— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Cyclical recovery narrative priced in, but heavy debt and regulatory shifts keep growth unconfirmed.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Charles River Laboratories
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purp…
- Sector:
- Healthcare
- Industry:
- Diagnostics & Research
- Market Cap:
- $8.8B
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Charles River Laboratories and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free